Prescription opioids

FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing in federal bankruptcy court. State attorneys general who are pressing separate state claims against the Sacklers want their cases to continue even as Purdue’s bankruptcy case plays out. They will make that argument on Friday, Oct. 11, 2019 before a bankruptcy judge in White Plains, New York. (AP Photo/Frank Franklin II, File)
October 11, 2019 - 8:02 pm
WHITE PLAINS, N.Y. (AP) — A judge is pushing for a settlement of more than 2,600 lawsuits facing OxyContin maker Purdue Pharma with a decision Friday to pause litigation against the company and members of the wealthy Sackler family that owns the company. In a hearing Friday, U.S. Bankruptcy Judge...
Read More
FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing in federal bankruptcy court. State attorneys general who are pressing separate state claims against the Sacklers want their cases to continue even as Purdue’s bankruptcy case plays out. They will make that argument on Friday, Oct. 11, 2019 before a bankruptcy judge in White Plains, New York. (AP Photo/Frank Franklin II, File)
October 11, 2019 - 2:20 pm
A judge will halt lawsuits against Purdue Pharma and its owners for six months in hopes of finalizing a settlement over the OxyContin maker's role in the national opioid crisis, he said Friday. In a hearing, U.S. Bankruptcy Judge Robert Drain strongly brushed aside the argument from a group of...
Read More
FILE - This Aug. 29, 2018, file photo shows an arrangement of prescription oxycodone pills in New York. U.S. health officials are again warning doctors against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors Thursday, Oct. 10, 2019, to share such decisions with patients. (AP Photo/Mark Lennihan, File)
October 10, 2019 - 12:19 pm
U.S. health officials again warned doctors Thursday against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors to share such decisions with patients. The agency published steps for doctors in a six...
Read More
FILE - This Aug. 29, 2018, file photo shows an arrangement of prescription oxycodone pills in New York. U.S. health officials are again warning doctors against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors Thursday, Oct. 10, 2019, to share such decisions with patients. (AP Photo/Mark Lennihan, File)
October 10, 2019 - 11:03 am
U.S. health officials are again warning doctors against abandoning chronic pain patients by abruptly stopping their opioid prescriptions. The U.S. Department of Health and Human Services instead urged doctors to share such decisions with patients. The agency Thursday published steps for doctors in...
Read More
FILE - In this Tuesday, June 19, 2018 file photo Cheryl Juaire walks past a photo of her son, Corey Merrill, at her home in Marlborough, Mass. Victims of opioid addiction weren’t in the room when big decisions were hammered out in OxyContin maker Purdue Pharma’s proposal to settle claims over its role in the U.S. opioid crisis. Cheryl Juaire lost her 23-year-old son to a heroin overdose after he became addicted to prescription painkillers. (AP Photo/Steven Senne, File)
October 06, 2019 - 3:50 pm
Victims of opioid addiction weren't in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company's role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched by...
Read More
FILE - In this Tuesday, June 19, 2018 file photo Cheryl Juaire walks past a photo of her son, Corey Merrill, at her home in Marlborough, Mass. Victims of opioid addiction weren’t in the room when big decisions were hammered out in OxyContin maker Purdue Pharma’s proposal to settle claims over its role in the U.S. opioid crisis. Cheryl Juaire lost her 23-year-old son to a heroin overdose after he became addicted to prescription painkillers. (AP Photo/Steven Senne, File)
October 06, 2019 - 11:58 am
Victims of opioid addiction weren't in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company's role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched by...
Read More
FILE - In this Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the nation’s opioid crisis will be at the center of a hearing in federal bankruptcy court. State attorneys general who are pressing separate state claims against the Sacklers want their cases to continue even as Purdue’s bankruptcy case plays out. They will make that argument on Friday, Oct. 11, 2019 before a bankruptcy judge in White Plains, New York. (AP Photo/Frank Franklin II, File)
October 04, 2019 - 5:26 pm
Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday blasted the terms of Purdue Pharma's offer to settle thousands of lawsuits over the nation's opioid crisis in court filings that also said the company had funneled up to $13 billion to...
Read More
October 04, 2019 - 4:56 pm
Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday blasted the terms of OxyContin maker Purdue Pharma's offer to settle thousands of lawsuits over the toll of the nation's opioids crisis. Their legal filings said the tentative deal does...
Read More
In this Sept. 26, 2019, photo, cars pass Rockefeller University in New York. Prestigious universities around the world, including Rockefeller, have accepted at least $60 million over the past five years from the family that owns the maker of OxyContin, even as the company became embroiled in lawsuits related to the opioid epidemic, financial records show. Rockefeller accepted more money from the Sacklers than any other school in recent history. (AP Photo/Mark Lennihan)
October 03, 2019 - 2:36 pm
BOSTON (AP) — Prestigious universities around the world have accepted at least $60 million over the past five years from the family that owns the maker of OxyContin, even as the company became embroiled in lawsuits related to the opioid epidemic, financial records show. Some of the donations...
Read More
FILE - In this July 13, 2013, file photo, rapper Mac Miller performs on his Space Migration Tour in Philadelphia. U.S. prosecutors say three men arrested during the investigation into rapper Mac Miller’s deadly overdose last year have now been charged with providing the drugs that killed him. A grand jury indictment unsealed Wednesday, Oct. 2, 2019 in Los Angeles accuses the men of conspiring and distributing cocaine and oxycodone pills laced with fentanyl that caused Miller’s death in September 2018. (Photo by Owen Sweeney/Invision/AP, File)
October 02, 2019 - 8:12 pm
LOS ANGELES (AP) — Three men arrested during the investigation into rapper Mac Miller’s deadly overdose last year have now been charged with providing the drugs that killed him, U.S. prosecutors said Wednesday. A grand jury indictment that was unsealed in Los Angeles accuses the men of conspiring...
Read More

Pages